Nope. It was a Pilot and they are not sure about doing more exomes.

From my last chat with Brian Naughton (their lead informatics guy) about this, it sounds like they are planning on doing more sequencing in the future. But it could be whole genome and it may be geared more towards research (your selected based on your phenotype) than open to any customer.